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A B S T R A C T
One of the widely used applications of the popular Cre-loxP method for targeted recombination is the permanent
activation of marker genes, such as reporter genes or antibiotic resistance genes, by excision of a preceding
transcriptional stop signal. The STOP cassette consists of three identical SV40-derived poly(A) signal repeats and
is flanked by two loxP sites. We found that in addition to complete loxP-mediated recombination, limiting levels
of the Cre recombinase also cause incomplete recombination of the STOP cassette. Partial recombination leads to
the loss of only one or two of the three identical poly(A) repeats with recombination breakpoints always pre-
cisely matching the end/start of each poly(A) signal repeat without any relevant similarity to the canonical or
known cryptic loxP sequences, suggesting that this type of Cre-mediated recombination is loxP-independent.
Incomplete deletion of the STOP cassette results in partial read-through transcription, explaining at least some of
the variability often observed in marker gene expression from an otherwise identical locus.
1. Introduction
The Cre-loxP recombination system derived from bacteriophage P1
is one of the most popular site-specific recombination tools. This system
serves bacteriophage P1 to properly segregate P1 plasmids to daughter
cells at cell division [1–3]. When a pair of directly repeated 34 bp loxP
recombination sites is located on the same piece of DNA, P1 Cre re-
combinase excises the intervening DNA, releasing a circular DNA con-
taining one loxP site and leaving the second loxP site behind [4]. Since
its discovery, a vast number of applications of this recombination
system beyond bacteria have been developed in various species, in-
cluding in mouse cell lines [5] and transgenic mice [6,7].
Transgenically modified Cre-responder mouse strains which express
fluorescent reporter proteins are now widely used to label specific cell
populations, for instance to localize tagged cells within specific organs
or to trace them during development or disease (fate mapping) [8]. A
popular variant of this approach is Cre expression profiling using Cre
recombinase-mediated excision of a transcriptional STOP cassette,
flanked by directly repeated loxP sites, which is placed between a
strong promoter and a marker gene. While this technique has originally
been developed for targeted oncogene activation [7], it can also be used
to permanently activate easily detectable reporter genes. Knock-in
strategies allowed for the insertion of such conditional reporter genes
into the permissive Rosa26 locus [9], providing a highly versatile tool
to visualize the cell-type specificity of virtually any kind of promoter/
Cre combination, following crossing of a Cre mouse strain with the
reporter mouse strain. Using this approach, Madisen et al. [10] devel-
oped a set of Cre reporter mice, including the Ai14 strain, that em-
ployed a previously reported STOP cassette containing three identical
254 bp poly(A) signal repeats derived from the SV40 virus [11].
We recently generated a novel BAC transgenic mouse model where
over 200 kb of the mouse Epo locus have been used to drive the ex-
pression of the conditional (i.e. tamoxifen-inducible) CreERT2 protein
[12]. These animals were crossed with Ai14 reporter mice, containing
the tandem dimeric Tomato (tdT) fluorescence reporter gene preceded
by the loxP-flanked STOP cassette. Following exposure to tamoxifen
and oxygen-deprived (hypoxic) conditions, this mouse model allowed
for the permanent fluorescent tagging of renal Epo-producing (REP)
cells [12]. During the isolation and cloning of REP-derived cell lines, we
noticed lower tdT fluorescence in some of the cells. This finding was
unexpected since tdT is expressed from the same endogenous single-
copy gene locus in all cells. We hence sought for an explanation of these
results and found a novel Cre activity, repeatedly resulting in partial
recombination of the STOP cassette.
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2. Materials and methods
2.1. Animals
The generation of Epo-CreERT2 (B6D2;C57BL6N-Tg
(EPO::Cre)nRhw) mice and the crossing with Ai14 reporter (B6.Cg-Gt
(ROSA)26Sor< tm14(CAG-tdTomato)Hze> /J) and Terminator
(B6.129-Gt(ROSA)26Sor< tm1(DTR)>) mice has been described
previously [12]. To induce Cre in vivo, tamoxifen (Sigma-Aldrich, St
Louis, MO, USA) at a dose of 200 mg/kg dissolved in corn oil/10%
ethanol was applied daily for 5 days by gavage followed by exposure of
the mice to 0.1% inspiratory carbon monoxide (CO) in air for 4 h as
described [12]. Alternatively, as a milder stimulus roxadustat (FG-
4592; Selleckchem, Houston, Texas, USA) was co-applied with tamox-
ifen by subsequent daily gavages for 5 days at a dose of 50 mg/kg
dissolved in 0.5 M Tris-HCl (pH 9.0). All animal experiments were
approved by the veterinary office of the canton Zurich (license numbers
ZH233/15 and ZH085/19).
2.2. Generation of renal cell lines
The generation of fibroblastoid atypical interstitial kidney (FAIK)
cell lines derived from kidneys of 2 to 3 months old female Epo-CreERT2
mice crossed with Ai14 reporter mice has been described in detail
previously [12]. Using the same protocol, we generated new REP-de-
rived (REPD) cell lines from kidneys excised from homozygous Epo-
CreERT2 mice containing one Ai14 and one Terminator allele in the
Rosa26 locus. AB-REPD cells were obtained from a 2 months old male
mouse 3 days after tamoxifen/0.1% CO induction of Cre in vivo. TK-
REPD cells were obtained from non-treated 2.5 months old female mice,
kept for 1 week in culture medium containing 10 μM tamoxifen and
B27 supplement (Invitrogen, Carlsbad, CA, USA) and exposed twice for
16 h to 0.2% O2 at day 1 and 7 before treatment with 100 ng/ml
diphtheria toxin until only a few tdT positive viable cells remained.
Clonal FAIK1-10 and polyclonal TK-REPD4 cell lines were immortalized
by lentiviral transduction with SV40 large T antigen as described [12].
Clonal AB-REPD2-22 were immortalized by gammaretroviral trans-
duction with a temperature sensitive SV40 large T (pLPCX SV40 tsA58;
kind gift from Parmjit Jat, London, UK) and cultured at 33 °C for ex-
pansion and at 37 °C for 3 to 7 days before harvest to prevent tem-
perature-dependent artifacts.
2.3. Cell culture and transfection
All renal cell lines were cultured as described previously [12].
Chinese hamster ovary (CHO) cells were cultured as reported pre-
viously [13]. Cells were transfected with lipofectamine 2000 (In-
vitrogen) in a 6-, 12- or 24-well format, using 2500 ng, 1600 ng or
500 ng, respectively, of total plasmid DNA. Empty pBluescript vector
(Agilent, Santa Clara, CA, USA) was used to keep the amount of total
DNA constant in titration experiments with the pBOB-CAG-iCre-SD
plasmid (kindly provided by Inder Verma; plasmid # 12336; Addgene,
Middlesex, UK) or the pCAG-ERT2-Cre-ERT2 plasmid [14] (kindly
provided by Connie Cepko; plasmid # 13777; Addgene). Cells co-
transfected with pCAG-ERT2-Cre-ERT2 and pAi9 (kindly provided by
Hongkui Zeng; plasmid # 22799; Addgene) were treated for 48 h with
4-hydroxy-tamoxifen (Sigma-Aldrich) or solvent (ethanol), starting 16 h
after transfection.
2.4. Cell analysis
Cellular tdT expression was analyzed by fluorescence microscopy or
FACS. For fluorescence microscopy, live cells were analyzed on an
Eclipse Ts2R inverted microscope (Nikon, Tokyo, Japan) and images
were acquired using NIS-Elements imaging software (Nikon). Exposure
time and gain were kept constant for all acquired images within an
experimental series. For confocal images, OCT-embedded tissue sec-
tions were analyzed on a Leica SP5 Mid UV-VIS microscope (Leica
Microsystems, Wetzlar, Germany) and images were acquired using LAS
X software (Leica Microsystems). Images were processed and analyzed
using the Fiji distribution of ImageJ [15,16]. For FACS analysis, cells
were detached using 2 mM EDTA (pH 8.0) in PBS, pelleted and re-
suspended in PBS. Cells were analyzed on a LSRII Fortessa FACScanner
(Becton Dickinson, Franklin Lakes, NJ, USA). tdT fluorescence was
excited using a 561 nm laser and detected using a 586/15 nm filter.
Dead cells were excluded by 4′,6-diamidino-2-phenylindole (DAPI;
Sigma-Aldrich) nuclear staining, using a 405 nm laser and a 450/50 nm
filter. Data was analyzed using FlowJo software (FlowJo, Ashland, OR,
USA).
2.5. RNA analysis
RNA was extracted and quantified by reverse-transcription (RT)
real-time quantitative (q) PCR as described previously [12]. In brief, RT
was performed with 2 μg total RNA and AffinityScript reverse tran-
scriptase (Agilent), and the cDNA quantified using SYBR Green qPCR
reagent kit (Kapa Biosystems, London, UK) in a MX3000P light cycler
(Agilent). Transcript levels were calculated by comparison with cali-
brated standard curves and normalized to mouse ribosomal protein L28
mRNA. Primers used for RT-qPCR are listed in Supplementary Table 1
and were purchased from Microsynth (Balgach, Switzerland).
2.6. DNA analysis
DNA was isolated as described previously [12] and 100 ng per re-
action were amplified by PCR (30–35 cycles of 95 °C/10 s, 64 °C/30 s,
72 °C/30 s) using KAPA2G Fast DNA polymerase (Kapa Biosystems) and
the primers listed in Supplementary Table 1. PCR products were ana-
lyzed by agarose gel electrophoresis, gel-purification and DNA se-
quencing (Microsynth), either directly or following sub-cloning into
pBluescript vector (Agilent) using XhoI and EcoRI restriction enzymes
(Thermo Fisher Scientific, Waltham, MA, USA).
3. Results
3.1. Clonal variation in Cre-activated reporter fluorescence intensities
During isolation of primary tdT-positive REP cells from the kidneys
of Epo-CreERT2 × Ai14 mice [12], we repeatedly observed single cells
with lower tdT fluorescence intensity. This variation in tdT fluorescence
was rather unexpected because tdT was expressed from the same con-
stitutively active single-copy Rosa26 locus (Fig. 1A) in all cells ana-
lyzed. Following immortalization and expansion, pellets of TK-REPD4
cells appeared red whereas pellets of AB-REPD2-22 remained pale
(Fig. 1B). Quantification of tdT mRNA demonstrated that tdT fluores-
cence intensity correlates with tdT transcript levels (Fig. 1C). In order to
control for proper CreERT2-mediated recombination of the loxP-flanked
STOP cassette, genomic DNA was analyzed by PCR using the primers
indicated in Fig. 1A (see Supplementary Table 1 for sequences). Sur-
prisingly, the PCR product of 201 bp (i.e. the predicted length after
loxP-mediated recombination) was only detected in the REPD cell line
TK-REPD4 (tdT high) whereas AB-REPD2-22 (tdT low) displayed a
longer PCR product (Fig. 1D). The previously reported FAIK1-10 cell
line [12] contains a non-recombined Ai14 locus (tdT null) which re-
sulted in the expected 1072 bp PCR product (Fig. 1D). Direct sequen-
cing of these PCR products revealed the deletion of all three poly(A)
signal repeats in TK-REPD4 cells, but one remaining poly(A) signal
repeat as well as both loxP sites and linker regions (the sequences be-
tween the loxP sites and the trimeric poly(A) signal repeats) in AB-
REPD2-22 cells (Supplementary Fig. 1). In total, we obtained ten par-
tially recombined AB-REPD cell clones, derived from two independent
primary cell isolations, with one remaining poly(A) signal repeat (data
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not shown).
3.2. Cre dose-dependent sequential recombination of an endogenous STOP
cassette
AB-REPD2-22 cells were obtained from primary REP cells isolated
from mice treated with tamoxifen and a brief hypoxia exposure in vivo
three days prior isolation. In contrast, TK-REPD4 cells were obtained
from primary REP cells of untreated mice and were stimulated with
tamoxifen and repeated hypoxia in vitro. Stronger transcriptional Cre
induction and better tamoxifen accessibility in vitro than in vivo suggest
that more CreERT2 was transcriptionally induced and translocated into
the nucleus during TK-REPD4 than AB-REPD2-22 generation, leading to
the hypothesis that a nuclear CreERT2 dose-dependent effect is re-
sponsible for the incomplete STOP cassette recombination. To analyze
whether Cre dose-dependent sequential deletion of one, two or all three
poly(A) signal repeats of the STOP cassette leads to a progressive in-
crease in tdT expression (Fig. 2A), tdT null FAIK1-10 cells were tran-
siently transfected with increasing amounts of an improved Cre (iCre)
expression vector, or constant amounts of a tamoxifen-inducible Cre
(ERT2-Cre-ERT2) expression vector, followed by treatment with in-
creasing concentrations of tamoxifen. In both cases, cells with variable
tdT fluorescence intensities were obtained, demonstrating that this ef-
fect is independent of a particular Cre protein modification (Fig. 2B).
While approx. 75% of all tdT-positive red cells were tdT low (blue in
Fig. 2B, lower panel) after low amount iCre transfection, only 7% re-
mained tdT low after high iCre transfection. Similarly, 26% were tdT
low in the absence of tamoxifen (owing to the strong ERT2-Cre-ERT2
overexpression) but only 4% remained tdT low in the presence of 1 μM
tamoxifen. It should be noted that for over 40 passages of in vitro cul-
tivation we never observed any tdT-positive FAIK1-10 cells, neither
under hypoxic conditions nor in the presence of tamoxifen or hydroxy-
tamoxifen (data not shown), demonstrating that in the absence of
exogenous Cre no STOP cassette recombination occurs.
Incomplete STOP cassette recombination was confirmed by FACS
analysis, clearly showing that, besides non-recombined (corresponding
to the naïve FAIK1-10 population) and fully recombined (corresponding
to the TK-REPD4 population) cells, there was also a substantial number
of cells with intermediate tdT fluorescence intensity, corresponding to
the AB-REPD2-22 population (Fig. 2C). PCR analysis of the STOP cas-
sette again resulted in multiple bands, consistent with incomplete re-
combination (Fig. 2D). These PCR products were isolated from the gel,
sub-cloned and sequenced, confirming the iCre-dose-dependent se-
quential recombination of the three poly(A) signal repeats (Supple-
mentary Fig. 2). To confirm that Cre-mediated stepwise STOP cassette
deletion is not specific for non-recombined FAIK1-10 cells, partially
recombined AB-REPD2-22 cells were transfected with an iCre expres-
sion vector. Exogenous iCre expression resulted in a clear increase in
tdT fluorescence intensity (Fig. 2E). PCR amplification using primers
flanking the STOP cassette indicated that a large portion of the trans-
fected cells underwent complete recombination (Fig. 2F), resulting in
an increase in tdT mRNA levels (Fig. 2G).
3.3. Cre dose-dependent sequential recombination of an exogenous STOP
cassette
To exclude that this incomplete STOP cassette recombination might
occur only with the endogenous Ai14 reporter in the Rosa26 locus of
our genetically modified mouse strains, we repeated these experiments
using CHO cells transiently co-transfected with the Ai9 [10] reporter
plasmid (Fig. 3A) together with various Cre expression vectors as shown
in Fig. 3B. Varying degrees of tdT fluorescence intensities again sug-
gested partial recombination also of exogenous bacterial reporter
plasmids (Fig. 3C). PCR amplification using the primers indicated in
Fig. 3A, subcloning and sequencing confirmed sequential recombina-
tion of the tripartite STOP cassette (Supplementary Fig. 3). Of note, the
recombination breakpoints inside the STOP cassette always precisely
corresponded to the end/start of each poly(A) signal repeat without any
similarity to the loxP sequence, suggesting that this type of Cre-medi-
ated recombination is loxP-independent.
3.4. Mild Cre activation in vivo leads to a high proportion of cells with
decreased reporter gene expression
Because the initial observation of REP cells derived from hypoxic
kidneys with incomplete STOP cassette recombination may be based on
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Fig. 1. Variable tdT fluorescence intensities in clonal cell lines derived from the same reporter mouse strain.
(A) Scheme depicting the genetically modified Rosa26 locus of the Ai14 mouse strain, before (upper panel) and after (lower panel) Cre-mediated recombination,
resulting in tdT negative and positive, respectively, cells. (B) Cell pellets of REPD cell lines, generated from mouse kidneys containing the Epo-CreERT2 and Ai14
alleles. (C) tdTomato mRNA quantification by RT-qPCR of the cells displayed in (B). Shown are mRNA ratios between tdTomato and the ribosomal protein L28 as
mean values + SEM of n=4 independent experiments. Unpaired two-tailed Student's t-test was used to statistically evaluate the difference between the two cell lines
(**, p < 0.01). (D) Agarose gel analysis of PCR products obtained by amplification of the STOP cassette with the primers indicated by small arrows in (A).
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single cells with a coincidentially low Cre-mediated recombination
event in vivo, we reasoned that a milder Epo inducing and hence Cre
inducing stimulus would increase the proportion of tdT low REP cells in
Epo-CreERT2 × Ai14 mice. Therefore, we treated these mice with rox-
adustat (FG-4592), a compound that has recently been approved in
China for renal anemia therapy [17]. Roxadustat is a hypoxia-inducible
factor prolyl-4-hydroxylase inhibitor that was designed for a relatively
mild Epo induction to correct anemia in chronic kidney disease patients
[18]. Combined tamoxifen/roxadustat treatment induced tdT positive
REP cells in the mouse kidney (Fig. 4A). Automated analysis of full
kidney slices demonstrated that many REP cells showed a weaker tdT
fluorescence than others (Fig. 4B). To confirm that differences in
fluorescence intensities between different cells are not due to varying z-
planes, sequential images across the full 10 μm section were taken every
0 μM 0.1 μM 1 μM
FAIK1-10 cells + ERT2-Cre-ERT2 + 4OH-Tmx
high iCremedium iCrelow iCre
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Fig. 2. Incomplete Cre-mediated recombination of an endogenous tripartite STOP cassette.
(A) Scheme illustrating the incomplete recombination of the endogenous Ai14 locus, resulting in graded tdTomato expression. (B) Fluorescence microscopy of FAIK1-
10 cells following recombination of the naïve Ai14 locus by lipofection with increasing amounts (10-fold in each step) of constitutive iCre (left panel) or 4-hydroxy-
tamoxifen (4OH-Tmx; concentrations indicated) inducible ERT2-Cre-ERT2 (right panel). tdTomato fluorescence was either combined with brightfield images (upper
panel) or displayed as color-coded intensity images (lower panel). (C) FACS analysis of tdTomato fluorescence of the FAIK1-10 cell line before (left panel) or after
lipofection with iCre (middle panel). For reference, tdT null FAIK1-10, tdT low AB-REPD2-22 and tdT high TK-REPD4 cells were mixed before FACS analysis and
fluorescence intensity thresholds were set using the dsRed histogram (right panel). (D) Agarose gel analysis of PCR products obtained by amplification of the STOP
cassette of the cells shown in (C) with the primers indicated by small arrows in (A). (E) Fluorescence microscopy of AB-REPD2-22 cells before and after lipofection
with iCre, causing complete recombination of the partially recombined Ai14 locus. (F) PCR analysis performed as in (D) of the cells shown in (E). (G) tdTomato
mRNA quantification by RT-qPCR of the cells shown in (E). Shown are ratios between tdTomato and ribosomal protein L28 mRNA levels as mean values + SEM of
n = 3 independent experiments. Unpaired two-tailed Student's t-test was used to statistically evaluate the difference between the two differentially recombined AB2-
22 cell pools (*, p < 0.05).
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0.15 μm by confocal microscopy and reduced to a maximum intensity z-
projection (Fig. 4C). Applying the same lookup table as used in Figs. 2
and 3, a clear tdT fluorescence intensity difference across the entire cell
body could be demonstrated in tdT high compared to tdT low cells
(Fig. 4D). From the same mice, primary kidney cells were isolated and
expanded in vitro for several days. Microscopic analysis revealed dif-
ferent REP cell populations with diverse tdT fluorescence intensities
(Fig. 4E), confirming our in vivo observations.
4. Discussion
The artificial SV40-derived tripartite STOP cassette [11] is widely
used for many different applications in molecular biology. Our ob-
servations demonstrate that the Cre recombinase can cause, or is at
least involved in, partial recombination of this cassette by targeting the
end-start junctions of the three identical poly(A) signal repeats, leaving
one or two poly(A) sequences intact. Without the presence of Cre we
never observed any STOP cassette recombination, neither in vivo nor in
vitro. Importantly, the poly(A) sequence shows no significant similarity
to the loxP sequence and we did not find any abnormality in the two
loxP sites outside the STOP cassette: while only one loxP site remained
following complete (loxP-dependent) recombination, both loxP sites
were still present following (loxP-independent) excision of one or two
of the three poly(A) signal repeats. Overexpression of Cre in tdT null
FAIK1-10 as well as in tdT low AB-REPD2-22 was sufficient to com-
pletely remove the STOP cassette and fully restore tdT expression,
further confirming that the Cre-loxP system was not generally cor-
rupted in our experiments and that tdT mRNA expression is directly
related to the extent to which the STOP cassette is truncated.
What could be the mechanism(s) underlying the partial Cre-medi-
ated recombination of the STOP cassette? One possibility may be al-
ternative loxP-like sequences within the STOP cassette's SV40 poly(A)
repeats, which only partially match the canonical loxP sequence, such
as loxB, loxL and loxR sites [19] or other cryptic loxP sites [20–23].
However, when we aligned 36 different reported cryptic loxP sites to
the STOP cassette, the best matching sequence was only 59% identical
and covered only half of the 34 bp (cryptic) loxP site (#36 in Supple-
mentary Fig. 4). Ignoring the spacer region and considering only the
Cre recognition sequences thought to interact with Cre [23], one half of
the palindromic loxP site almost perfectly matched the STOP cassette
(#37 in Supplementary Fig. 5). However, there was one mismatch at a
crucial position remaining and the other half of the palindrome did not
match at all. In conclusion, while this highly similar cryptic recognition
sequence might be involved in Cre recruitment to the pA repeats, the
absence of any match with the second half of the palindromic sequence
suggests that other mechanisms than cryptic loxP sites may be involved.
Alternatively, the Cre recombinase may be recruited to the STOP
cassette via the flanking loxP sites and creates DNA breaks which are
then repaired. However, we sequenced 23 partially recombined STOP
cassettes (Supplementary Figs. 2 and 3) and never observed any mu-
tation, insertion or deletion at the end-start junctions of the three
identical poly(A) signal repeats. Therefore, non-homologous end
joining seems rather unlikely as a DNA repair mechanism. Regarding
the tripartite perfect repeats, homologous recombination DNA repair
proteins, possibly even recruited by the Cre recombinase, appear a
more likely mechanism causing partial recombination of the STOP
cassette.
Incompletely deleted tripartite poly(A) signal repeats led to partial
transcription through the STOP cassette and suggests a Cre dose-de-
pendent step-wise increase in marker/reporter expression. To our
knowledge, such a Cre-mediated but loxP-independent recombination
has not been reported before. A brief literature survey of this popular
method immediately revealed several examples with apparently inter-
mediary reporter or marker gene expression, in addition to cells with
maximal expression [24–27]. Although these examples were randomly
selected and certainly not comprehensive, they still illustrate that there
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Fig. 3. Incomplete Cre-mediated recombination of an exogenous tripartite STOP cassette.
(A) Scheme depicting the pAi9 bacterial plasmid. (B) pAi9 was transiently transfected into Chinese hamster ovary (CHO) cells together with the indicated Cre
expression vectors. (C) Fluorescence microscopy of transiently co-transfected CHO cells following recombination of the exogenous pAi9 plasmid. tdTomato fluor-
escence was either combined with bright-field images (upper panel) or displayed as color-coded intensity images (lower panel). (D) Agarose gel analysis of PCR
products obtained by amplification of the STOP cassette with the primers indicated by small arrows in (A), following transient co-transfection of CHO cells with
varying ratios between the 4-hydroxy-tamoxifen (4OH-Tmx; concentrations indicated) inducible ERT2-Cre-ERT2 Cre expression vector and the pAi9 reporter plasmid
as indicated.
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might always be a minor cell population with incomplete inactivation
of the STOP cassette. Especially for clonal experiments, it may be
worthwhile to analyze the recombination of the STOP cassette, using
the aforementioned method. Incomplete STOP cassette deletion should
also be considered when analyzing in vivo expression patterns because
weaker reporter signals may reflect lower Cre levels, despite being
expressed from the same ubiquitous Rosa26 locus, which will be re-
levant for e.g. positive/negative threshold decisions.
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Fig. 4. Varying tdTomato fluorescence intensity in
REP cells in vivo following mild Cre induction.
(A) Epo-CreERT2 × Ai14 conditional reporter mice
were treated with tamoxifen and roxadustat (FG-
4592) and kidneys were analyzed by fluorescence
microscopy (red, tdTomato; blue, nuclei; green,
tubular autofluorescence). (B) Computer-based
fluorescence intensity mapping of the kidney section
shown in (A). (C) Maximum intensity projection of a
z-stack of 69 confocal scans across a 10 μm kidney
slice. (D) Color-coded maximum intensity images of
z-, y- and x-projections confirm the independence of
the imaging plane. (E) Clonally proliferating cell
clusters of primary cells isolated from mice treated
as above. The cell clusters grew in the same dish and
image recording and processing were identical.
Color-coding as in (D) demonstrates equal differ-
ences in tdTomato fluorescence intensity. (For in-
terpretation of the references to color in this figure
legend, the reader is referred to the web version of
this article.)
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Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbagrm.2020.194568.
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Supplementary Table 1 
 



















Supplementary Figure 1 
 
Direct sequencing of the PCR products following amplification of the STOP cassette in FAIK1-10, TK-






































Detected by sequencing PCR products Cell lines____ 
naïve STOP cassette 1072 bp FAIK1-10 
minus 2 poly(A) repeats 564 bp AB-REPD2-22 




Supplementary Figure 2 
 
Sequencing of gel-isolated and sub-cloned PCR products following amplification of the STOP cassette 
in ERT2-Cre-ERT2-transfected-transfected tdT null FAIK1-10 cells. Grey, amplification/subcloning 
























Detected by sequencing PCR products Times detected 
naïve STOP cassette 1082 bp 3 
minus 1 poly(A) repeat 828 bp 1 
minus 2 poly(A) repeats 574 bp 15 





Supplementary Figure 3 
 
Sequencing of gel-isolated and sub-cloned PCR products following amplification of the STOP cassette 
in CHO cells co-transfected with the pAi9 plasmid together with expression vectors for ERT2-Cre-
ERT2. Grey, amplification/subcloning PCR primers (bold, restriction sites); yellow, loxP sequence; 
blue/green/violet, identical SV40 poly(A) signal sequences. 
 
 




















Detected by sequencing PCR products Times detected 
naïve STOP cassette 1082 bp 2 
minus 1 poly(A) repeat 828 bp 3 
minus 2 poly(A) repeats 574 bp 4 




Supplementary Figure 4 
 
Alignment between the STOP cassette (entire sequence between the two flanking loxP sites) and 34 
cryptic loxP sites (#2 to #35) previously reported in the indicated publications. For reference, the 
canonical 34 bp loxP sequence (#1) is indicated in bold. The canonical recognition sequence with all 
bases irrelevant for Cre-binding replaced by the ambiguous base N, as well as a 34 bp sequence with 
all bases except the TATA motifs flanking the 8 bp spacer region replaced by N, are included as #36 
and #37, respectively. Small letters denote mismatches between the cryptic and the canonical loxP 
sites. NCBI Blast software was used with a minimal length of 7 nt, allowing for maximally 2 
mismatches and 0 gaps. Nucleotides of the reported cryptic loxP sites matching the STOP cassette 
are underlined, and the longest possible alignments (Length) as well as the corresponding % 
sequence identity (Similarity) are indicated.  
 
# Recognition Spacer Recognition Length Similarity Reference 
 
1 ATAACTTCGTATA ATGTATGC TATACGAAGTTAT   7 bp 20.1% [19] 
 
2 ATcgCTTCGgATA ActTccTGc TATACGAAGTTAT   0 bp 00.0% [19] 
3 ATAACTTCGTATA ATGTAtgt TATcCGAAacata  12 bp 35.3% [19] 
4 ATcgCTTCGgATA Acttcctgt TATcCGAAacata   8 bp 22.9% [19] 
5 ATAACTTCGTATA ATGTATaa TATAaGctaaTtT   8 bp 23.5% [20] 
6 ATAACTTCGTATA ATGTATGa TATAtGttGgagc  10 bp 29.4% [20] 
7 ATAACTTCGTATA ATGTgatga TATACctttTTtT  17 bp 50.0% [20] 
8 ATAACTTCGTATA ATGTATGg aAcAaGAAGgaAg   7 bp 20.1% [20] 
9 ATAACTTCGTATA ATGTATGg aActCttttTTgT   7 bp 20.1% [20] 
10 ATAACTTCGTATA ATGTATGg TAacttAtaTggT   7 bp 20.1% [20] 
11 ATAACTTCGTATA ATGTATGg TgTcCacAGgcAa   7 bp 20.1% [20] 
12 ATAACTTCGTATA ATGgcaat TATACGAAGcTtg   8 bp 23.5% [20] 
13 ATAACTTCGTATA ATGTtcca TATAatgAcccAa   8 bp 23.5% [20] 
14 ATAACTTCGTATA ATGTATGt TATcattAaTata  14 bp 41.2% [20] 
15 AcAACcattTATA ATaTATaa TATAtGAtGTTAT   7 bp 20.1% [21] 
16 AgAACcattTATA ATaTATaa TATAtGAtGTTAT   7 bp 20.1% [21] 
17 AgAACcattTATA ATaTATaa TATAtGAtGTatc   7 bp 20.1% [21] 
18 ATAcaTaCGTATA tatgtata TATACatAtaTAT   0 bp 00.0% [21] 
19 caAACaagGTATA tgcctgta TATACGAAaTggT   9 bp 26.5% [21] 
20 ATAtCTgCaTAaA cTtTAcca TATAaGgtGaTAT   7 bp 20.1% [21] 
21 gTAACTgaGTATA tgcatata TATACGtAtaTAT   0 bp 00.0% [21] 
22 catAacTCGTATA tgcatata TATACGAAGTTAT   0 bp 00.0% [21] 
23 ATAttgaCaTATA tTaTAaag TATAaGtAGTTAT   7 bp 20.1% [21] 
24 ATAACTTCGTATA ATGTATaC TATACGAAGTTAT   7 bp 20.1% [22] 
25 ATAACTTCGTATA ATGTgTaC TATACGAAGTTAT   7 bp 20.1% [22] 
26 ATAACTTCGTATA AaGTATcC TATACGAAGTTAT   0 bp 00.0% [22] 
27 ATAACTTCGTATA AgaaAcca TATACGAAGTTAT   0 bp 00.0% [22] 
28 ATAACTTCGTATA taaTAcca TATACGAAGTTAT   0 bp 00.0% [22] 
29 ATAACTTCGTATA AgaTAgaa TATACGAAGTTAT   8 bp 23.5% [22] 
30 ATAACTTCGTATA cgaTAcca TATACGAAGTTAT   0 bp 00.0% [22] 
31 taccgTTCGTATA ATGTATGC TATACGAAGTTAT   7 bp 20.1% [22] 
32 ATAACTTCGTATA ATGTATGC TATACGAAcggta   7 bp 20.1% [22] 
33 AaAAtgaCaTATA tgtgtata TATAtatAtaTAT   7 bp 20.1% [23] 
34 ATAAaaaagTATA tatacata TATAtGgAtgaAT   7 bp 20.1% [23] 
35 ATtAtTTCtTtTg cttctttt TAaAattttTaAT   7 bp 20.1% [23] 
36 ATNACNNCNTATA NNNNNNNN TATANGNNGTNAT  20 bp 58.8% [23] 




Supplementary Figure 5 
 
Alignment between the STOP cassette (entire sequence between the two flanking loxP sites) and the 
canonical Cre recognition site (#1, bold) as well as 35 cryptic Cre recognition sites (#2 to #36) 
previously reported in the indicated publications. The canonical Cre recognition sequence with all 
bases irrelevant for Cre binding replaced by the ambiguous base N, as well as the Cre recognition 
sequence with all bases except for the TATA motif replaced by N, are included as #37 and #38, 
respectively. Bases required for Cre binding [23] are highlighted in blue. Small letters denote 
mismatches between the cryptic and the canonical loxP sites. LALIGN software was used with a 
minimal length of 4 nt, allowing for maximally 2 mismatches and 0 gaps. Nucleotides of the reported 
cryptic loxP sites matching the STOP cassette are underlined, and the longest possible alignments 
(Length) as well as the corresponding % sequence identity (Similarity) are indicated.  
 
# Recognition Sequence Length  Similarity Reference 
1 ATAACTTCGTATA  6 bp  46.2% [19] 
2 ATcgCTTCGgATA  7 bp  53.9% [19] 
3 TATcCGAAacata 10 bp  76.9% [19] 
4 TATAaGctaaTtT  8 bp  61.5% [20] 
5 TATAtGttGgagc  9 bp  69.2% [20] 
6 TATACctttTTtT 10 bp  76.9% [20] 
7 aAcAaGAAGgaAg 10 bp  76.9% [20] 
8 aActCttttTTgT  7 bp  53.9% [20] 
9 TAacttAtaTggT  8 bp  61.5% [20] 
10 TgTcCacAGgcAa  9 bp  69.2% [20] 
11 TATACGAAGcTtg  7 bp  53.9% [20] 
12 TATAatgAcccAa  9 bp  69.2% [20] 
13 TATcattAaTata  9 bp  69.2% [20] 
14 AcAACcattTATA  8 bp  61.5% [21] 
15 TATAtGAtGTTAT 10 bp  76.9% [21] 
16 AgAACcattTATA  9 bp  69.2% [21] 
17 TATAtGAtGTatc  7 bp  53.9% [21] 
18 ATAcaTaCGTATA  6 bp  46.2% [21] 
19 TATACatAtaTAT  9 bp  69.2% [21] 
20 caAACaagGTATA  8 bp  61.5% [21] 
21 TATACGAAaTggT  6 bp  46.2% [21] 
22 ATAtCTgCaTAaA  8 bp  61.5% [21] 
23 TATAaGgtGaTAT 10 bp  76.9% [21] 
24 gTAACTgaGTATA  7 bp  53.9% [21] 
25 TATACGtAtaTAT  5 bp  38.5% [21] 
26 catAacTCGTATA  9 bp  69.2% [21] 
27 ATAttgaCaTATA  8 bp  61.5% [21] 
28 TATAaGtAGTTAT  6 bp  46.2% [21] 
29 taccgTTCGTATA  4 bp  30.8% [22] 
30 TATACGAAcggta  6 bp  46.2% [22] 
31 AaAAtgaCaTATA  7 bp  53.9% [23] 
32 TATAtatAtaTAT  4 bp  30.8% [23] 
33 ATAAaaaagTATA  9 bp  69.2% [23] 
34 TATAtGgAtgaAT 10 bp  76.9% [23] 
35 ATtAtTTCtTtTg  8 bp  61.5% [23] 
36 TAaAattttTaAT 10 bp  76.9% [23] 
37 ATNACNNCNTATA 12 bp  92.3% [23] 
38 NNNNNNNNNTATA 13 bp 100.0% [23] 
